• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24620
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism (1829)
Event Date 06/28/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination device.
 
Event Description
It was reported that a right peroneal artery embolism occurred post right superficial femoral artery (sfa) stenting.The patient was enrolled in the (b)(6) study on (b)(6) 2016 and the index procedure was performed on the same day.The target lesion was located in the right leg mid superficial femoral artery (sfa) extending into the distal sfa with 90% stenosis and was 190mm long with a proximal and distal reference vessel diameter of 5.00mm, and was classified as tasc ii c lesion.The target lesion was treated with placement of a 6x150mm and a 6x100mm eluvia study stent.Following post-dilatation, residual stenosis was 0%.On (b)(6) 2016, during the index procedure, post deployment of the study stents, completion angiogram of the runoff revealed some evidence of embolism in the tibioperoneal trunk, which was decided to treat with aspiration thrombectomy.An additional angiogram was performed which revealed that the embolic material had moved into the proximal portion of the peroneal artery and the posterior tibial artery was widely patent.On the same day, the embolism noted in the proximal portion of the peroneal artery was treated with aspiration thrombectomy.A completion angiogram demonstrated that there was good flow through the peroneal artery, with no evidence of embolic material within the peroneal artery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8433839
MDR Text Key139239985
Report Number2134265-2019-02596
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2017
Device Model Number24620
Device Catalogue Number24620
Device Lot Number0018822229
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-